SGS acquires the M-Scan group

SGS group has acquired M-Scan, a group of chemical analysis laboratories specializing in advanced chemical and biochemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on mass spectrometry and chromatography.

"This acquisition clearly complements our vision to become one of the top players within the biologics testing arena (large molecules) said Chris Kirk, CEO of SGS. "The acquisition of M-Scan is a milestone in the implementation of our strategy to take advantage of the on-going, high-growth development of vaccines and monoclonal antibodies. M-Scan's global recognition and expertise together with its geographic footprint combined with the existing advanced analytical services in SGS Life Science provides an excellent platform for further growth and development.“

The M-Scan group currently consists of four laboratories supported by marketing offices in Europe together with agents in Korea, India and Singapore. It provides analytical services in the area of life science, including protein/glycoprotein analysis, pharmaceutical analysis, extractables/leachables and bioanalysis to support the drug development programme.

For further information, visit www.sgs.com